The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
The Threat of Pandemic Influenza: Are We Ready? - Workshop Summary
in this symposium have shown that sensitivity of the FRT/PCR approach for avian influenza viruses could be improved, but specificity is very good and costs promise to be cheaper than the immunologically based detection kits. More research is certainly needed to provide prepackaged reagents that could be used by early responders to detect influenza viruses in the environment. However, given the commercial success of this technology, which was used quite extensively during the anthrax attack in the fall of 2001, it is definitely worth pursuing avian influenza specific primer and probe development and validation of assays in real-world settings, such as those described in this symposium.
MODELING PANDEMIC PREPAREDNESS SCENARIOS: HEALTH ECONOMIC IMPLICATIONS OF ENHANCED PANDEMIC VACCINE SUPPLY
Jeroen K. Medema,4,5York F. Zoellnerb,6James Ryan,7Abraham M. Palachea8
Reprinted with permission from Elsevier. Published in Virus Research, Medema et al., 2004. Copyright 2004, Elsevier.
Influenza pandemic planning is a complex, multifactorial process, which involves public health authorities, regulatory authorities, academia and industry. It is further complicated by the unpredictability of the time of emergence and severity of the next pandemic and the effectiveness of influenza epidemic interventions. The complexity and uncertainties surrounding pandemic preparedness have so far kept the various stakeholders from joining forces and tackling the problem from its roots. We developed a mathematical model, which shows the tangible consequences of conceptual
Business Group Influenza, Solvay Pharmaceuticals BV, P.O. Box 900, Weesp 1380 DA, The Netherlands.
Department of Health Economics, Solvay Pharmaceuticals GmbH, P.O. Box 220, Hannover 30002, Germany.
Mapi Values, The Adelphi Mill, Bollington, Macclesfield, Cheshire SK105JB, UK.
The authors like to thank James Piercy of Mapi Values for the health economic support during development of the model and Professor Kristin L. Nichol of the University of Minnesota Medical School for her valuable comments on the manuscript.